Boniva (Ibandronate)

Boniva is called Bonviva in Europe.

Information about Boniva (Ibandronate):

Boniva (ibandronate) is a prescription medication used to prevent and treat osteoporosis in postmenopausal women. Osteoporosis is a condition where bones become weak and brittle, leading to an increased risk of fractures. 

Boniva works by slowing down the process of bone loss, thereby increasing bone mass and reducing the risk of fractures. Ibandronate Sodium active ingredient in Boniva, which is a bisphosphonate that specifically inhibits osteoclast-mediated bone resorption, thus aiding in bone density maintenance.

Product Highlights:

• Use to treatment and prevention of postmenopausal osteoporosis.
• Oral tablets are typically taken once a month.
• Proven to help increase bone mineral density and reduce the risk of fractures in postmenopausal women with osteoporosis.

Key Ingredient:

• Ibandronate Sodium

Key Benefits:

• Increases bone mineral density, helping to strengthen bones.
• Lowers the risk of spine fractures, which are common in osteoporosis.
• Monthly oral dosing administration options.

Direction for Use:

• Take the tablet once a month on an empty stomach, first thing in the morning, with a full glass of plain water. Remain upright for at least 60 minutes after taking the tablet to aid absorption and prevent irritation of the esophagus.

Safety Concern:

• Common side effects may include gastrointestinal issues such as nausea, abdominal pain, and heartburn. Other potential side effects include muscle or joint pain.
• Rare but serious risks include osteonecrosis of the jaw (a condition where the jawbone begins to die) and unusual fractures of the thigh bone.
• Regular monitoring by a healthcare provider is recommended to check bone health and adjust treatment as needed.

Avoid Boniva (Ibandronate) If:

• You are allergic to ibandronate or any other ingredients in Boniva.
• You have certain esophageal disorders (e.g., esophageal stricture or achalasia) that could interfere with proper swallowing or digestion.
• If you have severe renal impairment, as Boniva is primarily excreted through the kidneys, and its use in such conditions may increase the risk of adverse effects.
• Boniva is not recommended for use during pregnancy or breastfeeding due to potential risks to the fetus or infant.